nalmefene and moxifloxacin

nalmefene has been researched along with moxifloxacin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Andersen, MP; Graff, C; Højer, AM; Kallio, A; Kanters, JK; Matz, J; Struijk, JJ; Toft, E; Vainio, PJ1
Bhuiyan, TA; Graff, C; Kanters, JK; Matz, J; Melgaard, J; Nielsen, J; Struijk, JJ; Toft, E1

Trials

1 trial(s) available for nalmefene and moxifloxacin

ArticleYear
Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.
    Clinical drug investigation, 2011, Nov-01, Volume: 31, Issue:11

    Topics: Adult; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Biomarkers, Pharmacological; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Guidelines as Topic; Heart Rate; Humans; Long QT Syndrome; Male; Moxifloxacin; Naltrexone; Narcotic Antagonists; Placebos; Prospective Studies; Quinolines; Treatment Outcome; Young Adult

2011

Other Studies

3 other study(ies) available for nalmefene and moxifloxacin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
The T-peak-T-end interval as a marker of repolarization abnormality: a comparison with the QT interval for five different drugs.
    Clinical drug investigation, 2015, Volume: 35, Issue:11

    Topics: Adult; Biomarkers; Clinical Trials as Topic; Dihydropyridines; Electrocardiography; Female; Fluoroquinolones; Humans; Imidazoles; Indoles; Male; Moxifloxacin; Naltrexone; Pharmaceutical Preparations; Sotalol

2015